Evidence map›Paper›PMID 33512011›Full record

ArticleJournal of medical virology2021

Reports of three long-term lung disease following SARS-CoV-2 infection.

Silvia Piantoni, Luisa Salada, Enrico Colombo, Monia Mendeni, Ezio Damiolini, Diego Gatta, Donata Richini, Roberto Furloni, Paolo Airò, Mirko Scarsi

Open access · bronzeAbstract readCase ReportsLetter
In one paragraph

Article in Journal of medical virology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Silvia PiantoniRheumatology and Clinical Immunology Unit, ASST Spedali Civili, Brescia, Italy.ORCID https://orcid.org/0000-0003-0913-0197
Luisa SaladaCOVID Unit - Hospital of Esine, ASST Valcamonica, Esine, Brescia, Italy.
Enrico ColomboCOVID Unit - Hospital of Esine, ASST Valcamonica, Esine, Brescia, Italy.
Monia MendeniCOVID Unit - Hospital of Esine, ASST Valcamonica, Esine, Brescia, Italy.
Ezio DamioliniCOVID Unit - Hospital of Esine, ASST Valcamonica, Esine, Brescia, Italy.
Diego GattaCOVID Unit - Hospital of Esine, ASST Valcamonica, Esine, Brescia, Italy.
Donata RichiniCOVID Unit - Hospital of Esine, ASST Valcamonica, Esine, Brescia, Italy.
Roberto FurloniCOVID Unit - Hospital of Esine, ASST Valcamonica, Esine, Brescia, Italy.
Paolo AiròRheumatology and Clinical Immunology Unit, ASST Spedali Civili, Brescia, Italy.
Mirko ScarsiCOVID Unit - Hospital of Esine, ASST Valcamonica, Esine, Brescia, Italy.
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAged, 80 and overCombined Modality TherapyCOVID-19FemaleHumansLungLung DiseasesMaleMiddle AgedRecurrenceSARS-CoV-2Treatment Outcome

Identifiers

PMID33512011
PMCPMC8014074
OpenAlexW3123108558

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.